"QEI works every day to save sight by providing innovation and excellence in research, education and clinical care to reduce eye disease, improve eye health, and ultimately eliminate preventable blindness in the community."

During the past decade, Queensland Eye Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queensland Eye Institute" #1 collaborator was "Cliantha Research" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Queensland Eye Institute" are "Geographic Atrophy" (2 trials), "Cataract" (1 trials), "Corneal Astigmatism" (1 trials), "Dry Eye" (1 trials) and "Meibomian Gland Dysfunction" (1 trials). Many other conditions were trialed in "Queensland Eye Institute" in a lesser frequency.

Most popular intervention types in "Queensland Eye Institute" are "Drug" (5 trials), "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AZR-MD-001 High Dose" (1 trials), "AZR-MD-001 Low Dose" (1 trials), "AZR-MD-001 Mid Dose" (1 trials), "AZR-MD-001 Vehicle" (1 trials) and "Collection of ocular fluids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Queensland Eye Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Queensland Eye Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Queensland Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Queensland Eye Institute, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".